Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Current Assets (2019 - 2025)

Historic Current Assets for Vivos Therapeutics (VVOS) over the last 7 years, with Q3 2025 value amounting to $5.8 million.

  • Vivos Therapeutics' Current Assets fell 2180.02% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 2180.02%. This contributed to the annual value of $7.5 million for FY2024, which is 20365.7% up from last year.
  • Vivos Therapeutics' Current Assets amounted to $5.8 million in Q3 2025, which was down 2180.02% from $6.7 million recorded in Q2 2025.
  • Over the past 5 years, Vivos Therapeutics' Current Assets peaked at $39.4 million during Q2 2021, and registered a low of $2.0 million during Q3 2023.
  • Over the past 5 years, Vivos Therapeutics' median Current Assets value was $7.5 million (recorded in 2024), while the average stood at $12.1 million.
  • In the last 5 years, Vivos Therapeutics' Current Assets crashed by 8014.93% in 2022 and then soared by 27274.56% in 2024.
  • Over the past 5 years, Vivos Therapeutics' Current Assets (Quarter) stood at $27.3 million in 2021, then tumbled by 80.15% to $5.4 million in 2022, then crashed by 54.63% to $2.5 million in 2023, then skyrocketed by 203.66% to $7.5 million in 2024, then fell by 22.57% to $5.8 million in 2025.
  • Its Current Assets stands at $5.8 million for Q3 2025, versus $6.7 million for Q2 2025 and $3.6 million for Q1 2025.